Company: KVACU
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-109170
Chunk: 111

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 2
Chunk 111
---
 the redemption value of the ordinary
shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable
shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of September 30, 2025
and December 31, 2024, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants
to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share,
since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive
and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into
ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income
(loss) per share for the period presented.

Item 3. Quantitative and Qualitative Disclosures
about Market Risk

We are a smaller reporting
company and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure
Controls and Procedures

Disclosure controls and
procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed,
summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated
and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation
of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness
of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2025, as such term is defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have
concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Changes in Internal
Control over Financial Reporting

During the quarter ended September 30, 2025, there
were no changes in our internal control over financial reporting (as defined in Rules 13a